Current status and perspective of targeted radionuclide therapy for cancer
نویسندگان
چکیده
منابع مشابه
Targeted Radionuclide Therapy: Current status and potentials for future improvements
Purpose: Adequate dosimetry is mandatory for effective and safe peptide receptorradionuclide therapy. The radiation-dose to the bone marrow can be calculated from theresidence time of the radiopeptide in the blood, but it might be underestimated since stemcells express somatostatin-receptors. We verified the blood-method by comparing the resultswith bone marrow aspirations. Also...
متن کاملDevelopmental trends in targeted radionuclide therapy of neuroendocrine tumors
Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms including carcinoids, pancreatic neuroendocrine tumors, pituitary tumors, medullary thyroid carcinoma and phaeochromocytomas. The symptoms and the outcome of NETs differ considerably between patients depending on several factors. By labelling tracers with a radioisotope, the tracer acts as a ...
متن کاملTargeted Radionuclide Therapy
Targeted radiotherapy is an evolving and promising modality of cancer treatment. The killing of cancer cells is achieved with the use of biological vectors and appropriate radionuclides. Among the many advantages of this approach are its selectiveness in delivering the radiation to the target, relatively less severe and infrequent side effects, and the possibility of assessing the uptake by the...
متن کاملBone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer.
Although selective metabolic and receptor-based molecular agents will surely be included in the future of prostate cancer diagnosis and therapy, currently available inorganic compounds-such as 18F-NaF for the diagnosis of bony disease and 223RaCl2 for the therapy of bone metastases-were recently shown to be superior to standard 99mTc-phosphonates for diagnosis and 153Sm-ethylenediaminetetrameth...
متن کاملTargeted therapy for hepatocellular carcinoma: current status and future direction
Following the proof of evidence on the use of sorafenib in patients with advanced hepatocellular carcinoma (HCC), targeted therapy has become an important element in management of advanced HCC. Novel targeted therapies are designed to inhibit the aberrant signaling pathways or oncogenic mechanism at a molecular level with an aim to improve the clinical outcome. An increasing number of targeted ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Drug Delivery System
سال: 2014
ISSN: 0913-5006,1881-2732
DOI: 10.2745/dds.29.294